VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment

The antiangiogenic splice variant VEGF-A165b is downregulated in a variety of cancer entities, but little is known so far about circulating plasma levels. The present analysis addresses this question and examines circulating VEGF-A/VEGF-A165b levels in a collective of female high-risk breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Karsten, Maria Margarete, Beck, Maximilian Heinz, Rademacher, Angela, Knabl, Julia, Blohmer, Jens-Uwe, Jückstock, Julia, Radosa, Julia Caroline, Jank, Paul, Rack, Brigitte, Janni, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046696/
https://www.ncbi.nlm.nih.gov/pubmed/32108136
http://dx.doi.org/10.1038/s41598-020-59823-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046696/
https://www.ncbi.nlm.nih.gov/pubmed/32108136
http://dx.doi.org/10.1038/s41598-020-59823-5

Ejemplares similares